【摘要】 目的:为临床合理使用抗肿瘤药提供参考。方法:调取上海市32家样本医院2009-2012年用药数据,运用Excel统计分析抗肿瘤药的销售金额、年同比增长率、市场份额以及科室分布等,并对样本医院及抗肿瘤药进行分类汇总、排序。结果:4年间抗肿瘤药用量增长迅速,2012年销售金额增长率达12.80%;从治疗大类分析,抗肿瘤中成药、抗代谢药和抗肿瘤植物药一直稳居销售金额前三位,总计占所有类别抗肿瘤药的50%以上,在恶性肿瘤的治疗中发挥着举足轻重的作用;从具体品种分析,多西他赛和卡培他滨的市场份额最大,销售金额始终排序前2位,而培美曲塞和替吉奥胶囊则是增速较快的2个品种。结论:近年来,抗肿瘤药物的应用呈现快速增长趋势,高选择性、高效低毒性的抗肿瘤药需求增大,抗肿瘤中成药应用广泛。更多还原

【Abstract】 OBJECTIVE:To provide reference for the rational use of antitumor drugs in clinic. METHODS:The medication data of sample hospitals from Shanghai during 2009-2012 were collected and analyzed statistically by using Excel 2010 software in terms of consumption sum,year-on-year growth rate,market share of different drugs and hospitals,and prescription distribution among departments,etc. These sample hospitals and antitumor drugs were summarized and sorted. RESULTS:The amount of antitumor drug was soaring during the past 4 years,with a growth rate of 12.8% in 2012. By drug category Antitumor Chinese patent medicine and antimetabolites were the top two categories in the list of consumption sum,which accounted for 40% in the total and played important roles in malignant tumor therapy. By drug type,doceltaxel and capecitabine owned the largest market shares,accounting for 6.15% and 5.94%;while pemetrexed and Tegafur/gimeracil/oteracil potassium capsule showed the most significant increase. CONCLUSIONS:In recent years,the application of antitumor drugs in hospitals shows rapid growth. The demand of antitumor drugs with high selectivity,high potency and low side-effect is increasing,and antitumor Chinese patent medicine is widely used.更多还原